We recently welcomed Tina Teague to Mtech Access as a Senior Consultant in the NHS Insights and Interaction team. Tina has extensive experience across a range of sectors within the NHS, including senior commissioning, acute hospital operational management as well as primary care.
She will be supporting the NHS Insights and Interaction team in the development and delivery of advisory sessions for our pharmaceutical and medtech clients looking to stay one step ahead of changes in the NHS.
We sit down with Tina to find out more.
You’ve worked in a number of senior roles in the NHS – where do you feel your deepest experience lies?
I am fortunate enough to have worked in senior positions across various sectors in the NHS, ranging from the operational management of cancer services to senior commissioning in a Clinical Commissioning Group. Most recently I have been working in primary care in a variety of roles focused on development, resilience and sustainability.
In these roles I have experienced the different perspectives and the inter-organisational complexities of the healthcare service and gained a much better understanding of how changes in one area can impact other areas. This understanding was invaluable, as the majority of the positions that I have held in the NHS involved service development and service transformation.
What led you to Mtech Access? Where did you first hear about our work?
Before I joined Mtech Access, I worked with the NHS Insights and Interaction team as an NHS Associate. As an Associate I shared my experiences and perspective from my roles in the NHS with pharmaceutical and medtech clients to help them gain a deeper understanding of the health service and inform their market access strategies.
I got to interact with a wide range of other Associates from the NHS and a broad selection of Mtech Access clients from leading pharmaceutical and medtech companies. I benefited enormously from these experiences as they gave me the opportunity to hear what was going on in other areas of the NHS and exposed me to the innovations that are on offer.
Mtech Access have a good reputation amongst NHS colleagues as well as in the life sciences sector more broadly, so I was delighted to be offered the opportunity to join the team.
We are delighted that you’ve chosen to become part of team here at Mtech Access. How will you balance your work with Mtech Access and with the NHS?
It is really important for me to be able to do work that has an impact on delivery of front-line care. The flexibility of my new role at Mtech Access, enables me to also undertake various ad hoc work within the NHS meaning I can continue to support the NHS.
Through these roles I can stay close to the NHS, keeping up to date with the real issues facing colleagues within the system as they plan and implement new policy. This will enable me to continue to share current experiences with our clients.
I am excited about hopefully being able to bridge the gap between those who design and manage services in the NHS and those who have innovative solutions to support them.
The NHS is going through a period of great change, do you think there is scope for industry to make a positive contribution?
The NHS is changing again with the recent proposals outlined in the White Paper. This is a positive move, as I believe systems should evolve to acknowledge and reflect changing environments. However, the challenge for the NHS is being able to reorganise itself whilst continuing to deliver good quality care.
With the pandemic, we have seen probably the biggest challenge to face the NHS in its history. It has impacted all elements of the system. There is some recovery and restoration work to be done but this could bring opportunities for partners to step up and support the NHS. For example, we have seen the important role that technology and self-management played during the pandemic – how can industry support these changes to become usual practice?
What are you most looking forward to in your new role with Mtech Access?
I am keen to further strengthen Mtech Access’ reputation for effectively engaging with those working in the NHS and I am particularly interested to see how we can demonstrate the value back into the NHS for those who we work closely with. I am also excited about creating mutually beneficial opportunities for greater collaboration between the NHS and the life science sector.
If you’d like to know more about how our NHS Insights and Interaction team bring insights from the NHS to support pharmaceutical and medtech companies with their market access journey, please email email@example.com.